Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Pfizer has entered into a multi-year agreement to manufacture and supply Gilead Science’s experimental antiviral drug remdesivir, for the treatment of Covid-19 patients.
As part of the deal, Pfizer will provide contract manufacturing services at its McPherson, Kansas facility to produce and supply the drug candidate for Gilead.
Separately, Pfizer launched an initiative in March to develop Covid-19 vaccine and drugs. Pfizer chairman and CEO Albert Bourla said: “From the beginning, it was clear that no one company or innovation would be able to bring an end to the Covid-19 crisis.